Perinuclear anti-neutrophil cytoplasm antibodies (pANCA) detected by IIF represent a useful tool conveying the diagnosis of type 1 AIH and/or PSC. As other serological markers of autoimmune diseases, pANCA detection can suggest, but not supersede the clinical and imaging diagnosis.
Granito A., Muratori P., Tovoli F., Muratori L. (2021). Anti-neutrophil cytoplasm antibodies (ANCA) in autoimmune diseases: A matter of laboratory technique and clinical setting. AUTOIMMUNITY REVIEWS, 20(4), 1-3 [10.1016/j.autrev.2021.102787].
Anti-neutrophil cytoplasm antibodies (ANCA) in autoimmune diseases: A matter of laboratory technique and clinical setting
Granito A.
;Muratori P.;Tovoli F.;Muratori L.
2021
Abstract
Perinuclear anti-neutrophil cytoplasm antibodies (pANCA) detected by IIF represent a useful tool conveying the diagnosis of type 1 AIH and/or PSC. As other serological markers of autoimmune diseases, pANCA detection can suggest, but not supersede the clinical and imaging diagnosis.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Anti-neutrophil cytoplasm antibodies (ANCA) in autoimmune diseases-.pdf
accesso riservato
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per accesso riservato
Dimensione
470.44 kB
Formato
Adobe PDF
|
470.44 kB | Adobe PDF | Visualizza/Apri Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
